Related Experiment Videos
Aspirin protects low density lipoprotein from oxidative modification
K A Steer1, T M Wallace, C H Bolton
1Department of Medicine, University of Bristol.
Heart (British Cardiac Society)
|April 1, 1997
Summary
Aspirin protects low-density lipoprotein (LDL) from oxidative damage. This study shows aspirin reduces LDL modification, suggesting a new way aspirin may prevent atherosclerosis.
Area of Science:
- Biochemistry
- Cardiovascular Research
- Pharmacology
Background:
- Oxidative modification of low-density lipoprotein (LDL) is a key factor in atherosclerosis development.
- Aspirin is widely used for cardiovascular disease prevention, but its direct effects on LDL oxidation are not fully understood.
Purpose of the Study:
- To investigate the impact of aspirin on the susceptibility of LDL to oxidative modification.
- To explore potential mechanisms of aspirin's cardioprotective effects.
Main Methods:
- A before-and-after trial involving ten healthy volunteers receiving enteric-coated aspirin (300 mg daily for two weeks).
- In vitro and in vivo assessment of LDL oxidation using ultraviolet C (UVC) irradiation.
- Measurements included malondialdehyde production, conjugated dienes, and LDL electrophoretic mobility.
Main Results:
- Aspirin treatment significantly reduced malondialdehyde production in LDL exposed to UVC irradiation (30% decrease by 240 minutes).
- Aspirin also significantly decreased the UVC-induced increase in LDL relative electrophoretic mobility.
- These protective effects were observed both in vivo and in vitro.
Conclusions:
- Aspirin demonstrates a protective effect against LDL oxidative modification.
- This antioxidant action on LDL provides a potential additional mechanism for aspirin's role in preventing atherosclerosis.